Siladitya Ray, Forbes Staff

Author's posts

EU Drug Regulator Approves Pfizer-BioNTech Covid-19 Vaccine For Emergency Use

The European Union has so far managed to secure 2 billion doses of various Covid-19 vaccines.

Southern California’s ICU Availability Is At 0% As The Covid-19 Surge Grows

California reported 540 new hospitalizations from Covid-19 on Thursday, bringing the state’s total up to 16,426.

India Is Reportedly Seeking More Data On Oxford-AstraZeneca Vaccine Before Granting Emergency Authorization

Proposals for two vaccines have not been granted yet as neither managed to submit adequate safety or efficacy data.

U.S. Records All-Time High Of 3,157 New Covid-19 Deaths

Wednesday’s number may be slightly inflated due to reporting delays over Thanksgiving weekend.

U.K. Approves Pfizer-BioNTech’s Covid-19 Vaccine, The First Country To Do So

The vaccine will be available across the U.K. starting next week with the elderly and frontline healthcare workers being the first to receive a shot.

Europe May Not Get Covid-19 Vaccine Before 2021, Earliest Approval Process Scheduled For December 29

Moderna and Pfizer applied to the EU’s vaccine regulator this week.

AstraZeneca May Conduct Additional Trial For Covid-19 Vaccine After Acknowledging Errors In Initial Trial

The company’s CEO said the new trial will be conducted outside the U.S. and its data may not be adequate to lead to approval from the FDA.

China Launches Mass Testing In Three Cities, Sees Chaotic Scenes In Shanghai After Tracing Outbreak To Airport Workers

Local authorities said the minor outbreak in Shanghai was traced back to two airport workers.

More Than 2,000 People Died Of Covid-19 In The U.S. On Thursday, With Around 80,000 Now Hospitalized

The daily death count from Covid-19 crossed 2,000 is the first time since early May.

FDA Authorizes At-Home Covid-19 Test That Gives Results In 30 Minutes

Lucira Health’s single-use self-test will only be available with a prescription at the moment.